Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 3 minute read Healthcare Industry News PAVmed secures $2.4m to advance Veris Health’s implantable cancer monitoring technology PAVmed Inc., a diversified commercial-stage medical technology company, has completed a $2.37 million private placement financing, reinforcing its… byPallavi MadhirajuFebruary 25, 2025